These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37767966)

  • 1. Letter to the editor regarding "Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology".
    Ventura B
    Aust N Z J Psychiatry; 2024 Jan; 58(1):92-93. PubMed ID: 37767966
    [No Abstract]   [Full Text] [Related]  

  • 2. Author reply to Letter to the Editor regarding 'Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology'.
    Miceli McMillan R; Fernandez AV
    Aust N Z J Psychiatry; 2024 Jan; 58(1):93-94. PubMed ID: 37927156
    [No Abstract]   [Full Text] [Related]  

  • 3. Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology.
    Miceli McMillan R; Fernandez AV
    Aust N Z J Psychiatry; 2023 Jun; 57(6):783-788. PubMed ID: 36384307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapharmacological Safety Topics in Psychedelic-Assisted Psychotherapy.
    Calder A; Hasler G
    JAMA Psychiatry; 2023 Aug; 80(8):761-762. PubMed ID: 37256606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.
    Carhart-Harris RL; Leech R; Williams TM; Erritzoe D; Abbasi N; Bargiotas T; Hobden P; Sharp DJ; Evans J; Feilding A; Wise RG; Nutt DJ
    Br J Psychiatry; 2012 Mar; 200(3):238-44. PubMed ID: 22282432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.
    Pearson C; Siegel J; Gold JA
    J Neurol Sci; 2022 Mar; 434():120096. PubMed ID: 34942586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations.
    Miceli McMillan R; Jordens C
    Med Health Care Philos; 2022 Jun; 25(2):225-237. PubMed ID: 35064398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy.
    Hendricks PS
    Int Rev Psychiatry; 2018 Aug; 30(4):331-342. PubMed ID: 30260256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
    Majić T; Schmidt TT; Gallinat J
    J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compassionate use of psychedelics.
    Greif A; Šurkala M
    Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.
    Rosenblat JD; Leon-Carlyle M; Ali S; Husain MI; McIntyre RS
    Am J Psychiatry; 2023 May; 180(5):395-396. PubMed ID: 36945824
    [No Abstract]   [Full Text] [Related]  

  • 12. Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy.
    Horton DM; Morrison B; Schmidt J
    Am J Psychother; 2021 Dec; 74(4):140-149. PubMed ID: 34293927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Emerging Field of Psychedelic Psychotherapy.
    Barber GS; Aaronson ST
    Curr Psychiatry Rep; 2022 Oct; 24(10):583-590. PubMed ID: 36129571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychedelic-assisted psychotherapy, patient vulnerability and abuses of power.
    Meikle S; Carter O; Bedi G
    Aust N Z J Psychiatry; 2024 Feb; 58(2):104-106. PubMed ID: 37767944
    [No Abstract]   [Full Text] [Related]  

  • 15. Psilocybin-assisted therapy for depression: How do we advance the field?
    Meikle SE; Liknaitzky P; Rossell SL; Ross M; Strauss N; Thomas N; Murray G; Williams M; Castle DJ
    Aust N Z J Psychiatry; 2020 Mar; 54(3):225-231. PubMed ID: 31752499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.
    Stein CA; Penn A; Van Hope S; Dorsen CG; Mangini M
    J Midwifery Womens Health; 2022 May; 67(3):373-383. PubMed ID: 35522087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psilocybin for Trauma-Related Disorders.
    Khan AJ; Bradley E; O'Donovan A; Woolley J
    Curr Top Behav Neurosci; 2022; 56():319-332. PubMed ID: 35711024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations.
    Ortiz CE; Dourron HM; Sweat NW; Garcia-Romeu A; MacCarthy S; Anderson BT; Hendricks PS
    Neuropharmacology; 2022 Aug; 214():109127. PubMed ID: 35577136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychedelic-assisted psychotherapy: where is the psychotherapy research?
    Aday JS; Horton D; Fernandes-Osterhold G; O'Donovan A; Bradley ER; Rosen RC; Woolley JD
    Psychopharmacology (Berl); 2024 Aug; 241(8):1517-1526. PubMed ID: 38782821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychedelics and Psychedelic-Assisted Psychotherapy.
    Reiff CM; Richman EE; Nemeroff CB; Carpenter LL; Widge AS; Rodriguez CI; Kalin NH; McDonald WM;
    Am J Psychiatry; 2020 May; 177(5):391-410. PubMed ID: 32098487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.